Febuhelp 40mg Tablet contains Febuxostat, a xanthine oxidase inhibitor used primarily to manage hyperuricemia in patients with gout. By selectively inhibiting the enzyme xanthine oxidase, Febuxostat reduces the production of uric acid, thereby lowering serum urate levels and preventing the formation of urate crystals that cause gout attacks. This medication is indicated for the long-term management of chronic gout and is particularly beneficial for patients who are intolerant to or inadequately controlled by other urate-lowering therapies such as allopurinol. Febuhelp 40mg is typically administered once daily, with or without food, and dosage adjustments may be necessary based on renal function and clinical response. Common side effects include nausea, joint pain, and rash, while rare but serious adverse effects may involve liver function abnormalities and cardiovascular events, necessitating regular monitoring by a healthcare professional. Patients are advised to maintain adequate hydration and avoid alcohol consumption during treatment. Febuhelp should be used cautiously in individuals with a history of cardiovascular disease or hepatic impairment. Overall, Febuhelp 40mg Tablet offers an effective option for controlling hyperuricemia and reducing the frequency of gout flares, improving patient quality of life when used as directed under medical supervision.

Dosage & How to Use